ClinicalTrials.gg
Not yet recruitingNCT05744154Updated Feb 24, 2023

Reducing Low-value Care for Trauma Admissions

An interventional study of Audit & feedback with educational outreach and facilitation and Simple audit & feedback (usual practice) in Trauma Injury, sponsored by Laval University. Not yet recruiting at 1 site in Canada. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2023-02-24.

Sponsored by Laval University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 1 month ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

In Canada, injury leads to more potential years of life lost and to greater costs than heart and stroke diseases combined. Furthermore, more than 50% of patients hospitalised following injury do not receive optimal care, 20% of injury deaths are estimated to be preventable, and significant variations in injury mortality and morbidity have been observed across trauma centers in Canada, the United Kingdom, Australia and the United States. Over the past decades, emphasis on adherence to evidence-based processes of care (rewards for doing more) and rapid innovation in imaging and therapeutic techniques has led to an exponential rise in unnecessary tests and procedures. Whole body computed tomography scan for single-system trauma is just one example. Low-value clinical practices, defined as "the common use of a particular intervention when the benefits don't justify the potential harm or cost" consume up to 30% of healthcare budgets. They expose patients to physical and psychological adverse events and put enormous pressure on healthcare budgets, thereby threatening accessible, universal health care. The objective of this research project is to evaluate the effectiveness of an intervention targeting reductions in low-value clinical practices for injury admissions. The results of this study should directly lead to improvements in the health systems across Canada and elsewhere. Medium and long-term advantages include an increase in healthcare efficiency and effectiveness, a reduction in costs, an increase in the availability of resources for patients who need them and a reduction in adverse events for patients hospitalized following injury.

Read the detailed description

RATIONALE: While simple Audit \& Feedback (A\&F) has shown modest effectiveness for reducing low-value care, there is a knowledge gap on the effectiveness of multifaceted interventions to support de-implementation efforts. Given the need to make rapid decisions in a context of multiple diagnostic and therapeutic options, trauma is a high-risk setting for low-value care. Furthermore, trauma systems are a favorable setting for de-implementation interventions as they have quality improvement teams with medical leadership, routinely collected clinical data, and performance linked to accreditation.

OBJECTIVES: We aim to evaluate the effectiveness of a multifaceted intervention for reducing low-value clinical practices in acute adult trauma care.

METHODS: We will conduct a pragmatic cluster randomized controlled trial. Level I-III trauma centers in an inclusive Canadian trauma system (n=29) will be randomized (1:1) to receive simple A\&F (control) or a multifaceted intervention (intervention). The multifaceted intervention, developed using extensive background work and United Kingdom Medical Research Council guidelines for the Development of Complex Interventions, includes an A\&F report, educational materials, virtual educational meetings, and virtual facilitation visits. The primary outcome will be patient-level use of low-value initial diagnostic imaging, assessed using routinely collected trauma registry data. Secondary outcomes will be low-value specialist consultation, low-value repeat imaging for transfers, unintended consequences, and Incremental Cost-Effectiveness Ratios.

IMPACT: This innovative, timely research project will advance knowledge on the incremental effectiveness of a multifaceted intervention over simple A\&F to de-implement low-value care. The intervention has a high probability of success because it targets a problem identified by stakeholders, is based on extensive background work, is low-cost, and is linked to accreditation. This intervention has the potential to reduce the adverse effects and indirect expenses of low-value trauma care for patients and families. It could also free up resources, reduce delays to care, and decrease healthcare professionals' workload, at a time of unprecedented strain on healthcare resources.

02

Conditions studied

  • Trauma Injury

Browse trials for

Keywords

  • Low-value care
  • Multifaceted intervention
  • De-implementation
  • Trauma system
03

In context

Accidental Injuries

57 studies on the registry are indexed under Accidental Injuries; 30 are open to participants now.

This study's planned enrollment of 29 is below the median of 122 across 36 interventional studies indexed under Accidental Injuries.

Browse Accidental Injuries studies →

Lead sponsor

Laval University is the lead sponsor of 380 studies on the registry; 70 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: All adult level I-III trauma centers in the Trauma Care Continuum of the province of Québec -

Exclusion Criteria: Level IV centers (patient volume too low)

-

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
29 participants (estimated)

Study arms

  • Experimental
    Audit & feedback with educational outreach and facilitation

    The intervention includes: 1) refinement with end users, 2) an A\&F report sent to local governing authorities presenting for each practice: performance compared to peers (simple A\&F), a summary message indicating if action is required and a list of potential actions, 3) educational materials (a clinical vignette; consequences of the practice; links to practice guidelines, clinical decision rules and shared decision-making tools; a case review tool), 4) virtual educational meetings with the local trauma Medical Director, trauma program manager and data analyst, and 5) two virtual facilitation visits 2 and 4 months after the transmission of the report to support committees in preparing their action plan.

    Behavioral: Audit & feedback with educational outreach and facilitation

  • Other
    Simple audit & feedback

    The control arm will receive the quality improvement intervention currently in place in the Québec Trauma Care Continuum (i.e. simple A\&F report presenting their performance compared to peers on quality indicators measuring adherence to high-value care and risk-adjusted outcomes) with the addition of quality indicators on low-value care (already planned by provincial authorities for the 2023 evaluation cycle). Simple A\&F was chosen for the control because it is standard practice in Québec and in most integrated trauma systems and the effectiveness of A\&F for de-implementation has been documented.

    Behavioral: Simple audit & feedback (usual practice)

Interventions

  • BehavioralAudit & feedback with educational outreach and facilitation

    As in arm descriptions

  • BehavioralSimple audit & feedback (usual practice)

    As in arm descriptions

06

What researchers measure

Primary outcomes

  1. Low-value initial diagnostic imaging

    Proportion of low-risk patients who receive head, cervical spine or whole-body computed tomography in the emergency department

    Time frame: 18-month interval (6 to 24 months) after implementation

Secondary outcomes

  1. Low-value specialist consultation

    Proportion of low-risk patients who receive neurosurgical or spine surgery consultation

    Time frame: 18-month interval (6 to 24 months) after implementation

  2. Pre-transfer imaging

    Proportion of patients with a clear indication to transfer who receive imaging in referral center

    Time frame: 18-month interval (6 to 24 months) after implementation

  3. Repeat post-transfer imaging

    Proportion of patients with imaging in referral center with no disease progression who are re-imaged in receiving center following transfer

    Time frame: 18-month interval (6 to 24 months) after implementation

Other outcomes

  1. Mortality

    Proportion of patients admitted who die in hospital

    Time frame: 18-month interval (6 to 24 months) after implementation

  2. Unplanned readmission

    Proportion of patients discharged alive with an unplanned readmission within 30 days of discharge

    Time frame: 18-month interval (6 to 24 months) after implementation

  3. Missed injuries

    Proportion of patients admitted for whom an injury was missed in the emergency department and later detected as an inpatient

    Time frame: 18-month interval (6 to 24 months) after implementation

  4. Hospital stay

    Mean hospital length of stay in days for all hospital admissions

    Time frame: 18-month interval (6 to 24 months) after implementation

  5. Intensive care unit stay

    Mean intensive care unit stay in days for all patients admitted to the intensive care unit

    Time frame: 18-month interval (6 to 24 months) after implementation

  6. Complications

    Proportion of patients admitted with an event of deep vein thrombosis/pulmonary embolism, decubitus ulcers, delirium, pneumonia, or urinary tract infection during their in-patient stay

    Time frame: 18-month interval (6 to 24 months) after implementation

  7. Incremental Cost-Effectiveness Ratios

    Economic evaluation

    Time frame: 0 to 24 months after implementation

07

Study locations

1 site
  • Université Laval
    Québec, Quebec, Canada
08

References and documents

Publications

  • Moore L, Berube M, Tardif PA, Lauzier F, Turgeon A, Cameron P, Champion H, Yanchar N, Lecky F, Kortbeek J, Evans D, Mercier E, Archambault P, Lamontagne F, Gabbe B, Paquet J, Razek T, Stelfox HT; Low-Value Practices in Trauma Care Expert Consensus Group. Quality Indicators Targeting Low-Value Clinical Practices in Trauma Care. JAMA Surg. 2022 Jun 1;157(6):507-514. doi: 10.1001/jamasurg.2022.0812. PubMed 35476055 ↗
  • Moore L, Berube M, Tardif PA, Lauzier F, Turgeon A, Cameron P, Champion H, Yanchar N, Lecky F, Kortbeek J, Evans D, Mercier E, Archambault P, Lamontagne F, Gabbe B, Paquet J, Razek T, Belcaid A, Berthelot S, Malo C, Lang E, Stelfox HT. Validation of Quality Indicators Targeting Low-Value Trauma Care. JAMA Surg. 2022 Sep 14;157(11):1008-16. doi: 10.1001/jamasurg.2022.3912. Online ahead of print. PubMed 36103195 ↗
  • Moore L, Lauzier F, Tardif PA, Boukar KM, Farhat I, Archambault P, Mercier E, Lamontagne F, Chasse M, Stelfox HT, Berthelot S, Gabbe B, Lecky F, Yanchar N, Champion H, Kortbeek J, Cameron P, Bonaventure PL, Paquet J, Truchon C, Turgeon AF; Canadian Traumatic brain injury Research Consortium. Low-value clinical practices in injury care: A scoping review and expert consultation survey. J Trauma Acute Care Surg. 2019 Jun;86(6):983-993. doi: 10.1097/TA.0000000000002246. PubMed 31124896 ↗
  • Soltana K, Moore L, Bouderba S, Lauzier F, Clement J, Mercier E, Krouchev R, Tardif PA, Belcaid A, Stelfox T, Lamontagne F, Archambault P, Turgeon A; Canadian Traumatic Brain Injury Research Consortium. Adherence to Clinical Practice Guideline Recommendations on Low-Value Injury Care: A Multicenter Retrospective Cohort Study. Value Health. 2021 Dec;24(12):1728-1736. doi: 10.1016/j.jval.2021.06.008. Epub 2021 Aug 18. PubMed 34838270 ↗
  • Abiala G, Berube M, Mercier E, Yanchar N, Stelfox HT, Archambault P, Bourgeois G, Belcaid A, Neveu X, Isaac CJ, Clement J, Lamontagne F, Moore L. Pre- and posttransfer computed tomography imaging in Canadian trauma centers: A multicenter retrospective cohort study. Acad Emerg Med. 2022 Sep;29(9):1084-1095. doi: 10.1111/acem.14536. Epub 2022 Jun 8. PubMed 35612384 ↗
  • Moore L, Tardif PA, Lauzier F, Berube M, Archambault P, Lamontagne F, Chasse M, Stelfox HT, Gabbe B, Lecky F, Kortbeek J, Lessard Bonaventure P, Truchon C, Turgeon AF. Low-Value Clinical Practices in Adult Traumatic Brain Injury: An Umbrella Review. J Neurotrauma. 2020 Dec 15;37(24):2605-2615. doi: 10.1089/neu.2020.7044. Epub 2020 Sep 30. PubMed 32791886 ↗
  • Berube M, Moore L, Tardif PA, Berry G, Belzile E, Lesieur M, Paquet J. Low-value injury care in the adult orthopaedic trauma population: A systematic review. Int J Clin Pract. 2021 Dec;75(12):e15009. doi: 10.1111/ijcp.15009. Epub 2021 Nov 30. PubMed 34816530 ↗
  • Berube M, Lapierre A, Sykes M, Grimshaw J, Turgeon AF, Lauzier F, Taljaard M, Stelfox HT, Witteman H, Berthelot S, Mercier E, Gonthier C, Paquet J, Fowler R, Yanchar N, Haas B, Lessard-Bonaventure P, Archambault P, Gabbe B, Guertin JR, Ouyang Y, Moore L; Canadian Traumatic Brain Injury Research Consortium. Development and usability testing of a multifaceted intervention to reduce low-value injury care. BMC Health Serv Res. 2025 Jan 7;25(1):37. doi: 10.1186/s12913-024-12153-y. PubMed 39773251 ↗
  • Moore L, Berube M, Belcaid A, Turgeon AF, Taljaard M, Fowler R, Yanchar N, Mercier E, Paquet J, Stelfox HT, Archambault P, Berthelot S, Guertin JR, Haas B, Ivers N, Grimshaw J, Lapierre A, Ouyang Y, Sykes M, Witteman H, Lessard-Bonaventure P, Gabbe B, Lauzier F; Canadian Traumatic Brain Injury Research Consortium (CTRC). Evaluating the effectiveness of a multifaceted intervention to reduce low-value care in adults hospitalized following trauma: a protocol for a pragmatic cluster randomized controlled trial. Implement Sci. 2023 Jul 7;18(1):27. doi: 10.1186/s13012-023-01279-y. PubMed 37420284 ↗

Individual participant data

Plan to share: Yes — Individual patient data are held by provincial authorities and cannot be transmitted by study investigators. Supporting material will be made available through the study program website.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Six months after publication of all study results up to 10 years after study initiation

Access criteria: Supporting data will be made available on request. Patient-level data from the provincial trauma registry can be accessed on request through provincial authorities.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2023; primary completion for Sep 2025, 27 months later.

Of 18 interventional studies with no phase under Accidental Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 59. This study's planned 27 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2023
First posted
Feb 24, 2023
StartEst.
Jun 2023
Primary completionEst.
Sep 2025
CompletionEst.
Dec 2026
Last update
Feb 24, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05744154
Lead sponsor
Laval University
Collaborators
Institut national en santé et services sociaux, Trauma Association of Canada, Health Standards Organisation, Choosing Wisely Canada, Audit & Feedback Metalab, Institut national de la pertinence des actes médicaux
Responsible party
Sponsor
First posted
Feb 24, 2023
Start date
Jun 2023 (estimated)
Primary completion
Sep 2025 (estimated)
Completion
Dec 2026 (estimated)
Last update
Feb 24, 2023

Study contacts

Lynne Moore, PhD
Contact
lynne.moore@fmed.ulaval.ca
4186490252 ext. 63366
Mélanie Bérubé, PhD
Contact
melanie.berube@fsi.ulaval.ca
4186490252 ext. 66600

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion